Lumati has announced the appointment of Ruta Laukien as Executive Director and Chairwoman of the Board, signifying a major milestone in the company’s pursuit of advancing longevity science and human performance. Her leadership is set to drive Lumati’s next phase of innovation, research, and global expansion.
With a mission to merge clinical science and cutting-edge longevity technologies, Lumati is building a transformative ecosystem focused on optimizing human vitality. The company’s initiatives-spanning advanced clinical research, wellness platforms, and personalized interventions-aim to make longevity-focused healthcare accessible and data-driven.
Professional Background
A seasoned investor and transformative leader, Ruta Laukien brings decades of multidisciplinary experience across capital markets, healthcare innovation, and entrepreneurship. She has held senior positions at GrayBella Capital, US Capital, Bear Stearns Companies, and Alantra, contributing to the growth of visionary companies through strategic funding and operational leadership.
Strategic Vision
Ruta’s appointment is expected to strengthen Lumati’s ability to scale its clinical research pipeline, expand its global ecosystem, and accelerate product innovation. Among its flagship initiatives, the Recharge Portal integrates multi-modal, science-backed interventions to enhance human performance and wellness outcomes.
Significance and Outlook
Under Laukien’s stewardship, Lumati is poised to advance its goal of impacting 1 billion lives by 2035. Her leadership—anchored in purpose, scientific rigor, and a human-centric approach-reflects the company’s broader vision to redefine the future of longevity and personalized health.
Share your Details for subscribe